top of page
Wegovy (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).
Wegovy®
Once a week subcutaneous injection
Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.
bottom of page